Dolby Laboratories (NYSE:DLB) Receives $90.75 Consensus Price Target from Analysts

Dolby Laboratories (NYSE:DLB) has received a consensus recommendation of “Moderate Buy” from the five analysts that are presently covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 1 year target price among brokers that have covered the stock in the last year is $90.75.

Several equities analysts have recently issued reports on the company. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Dolby Laboratories in a research note on Wednesday, June 24th. Rosenblatt Securities reiterated a “buy” rating and issued a $85.00 price objective on shares of Dolby Laboratories in a research report on Thursday, June 11th. Wall Street Zen raised Dolby Laboratories from a “hold” rating to a “buy” rating in a report on Saturday, May 30th. Finally, Barrington Research restated an “outperform” rating and set a $90.00 target price on shares of Dolby Laboratories in a research report on Monday, June 15th.

Dolby Laboratories News Roundup

Here are the key news stories impacting Dolby Laboratories this week:

• Positive Sentiment: Raised earnings outlook: Dolby guided fiscal 2026 adjusted EPS to $4.25-$4.40, above the $4.10 consensus. Fourth-quarter revenue guidance of $362 million-$392 million also exceeded estimates of $351.1 million, suggesting management expects stronger near-term performance. Dolby Laboratories Reports Q3 Results, Boosts Share Repurchases
• Positive Sentiment: Adjusted EPS beat expectations: Third-quarter adjusted earnings were $0.69 per share, topping the $0.67 consensus, while operating cash flow increased to $167.5 million. Dolby also announced an expansion of its share-repurchase authorization, which may support per-share value. Dolby Laboratories Reports Third Quarter 2026 Financial Results
• Neutral Sentiment: Mixed investor positioning: Institutional activity was divided, with 184 investors adding shares and 192 reducing positions during the latest quarter. Recent analyst price targets remained well above the current trading level, but the limited number of targets reduces their significance.
• Negative Sentiment: Revenue missed and declined: Third-quarter revenue was $305 million, below estimates ranging from roughly $312 million to $315 million and down 3.3% year over year. This suggests continued pressure in Dolby’s core licensing and technology businesses. Dolby Laboratories Reports Q3 Earnings
• Negative Sentiment: Profitability weakened: GAAP net income fell to $28.6 million and diluted EPS to $0.30 from the prior year, while operating profit declined to $34.3 million. In addition, reported insider transactions showed selling but no purchases over the past six months, a potential sentiment headwind.

Insider Buying and Selling at Dolby Laboratories

In related news, CMO Todd Pendleton sold 11,876 shares of the stock in a transaction that occurred on Friday, May 22nd. The shares were sold at an average price of $54.55, for a total value of $647,835.80. Following the transaction, the chief marketing officer directly owned 41,480 shares in the company, valued at $2,262,734. This represents a 22.26% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CFO Robert J. Park sold 4,895 shares of the stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $56.68, for a total transaction of $277,448.60. Following the completion of the transaction, the chief financial officer owned 81,490 shares in the company, valued at $4,618,853.20. This represents a 5.67% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 47,458 shares of company stock valued at $2,639,537. 37.93% of the stock is currently owned by corporate insiders.

Institutional Trading of Dolby Laboratories

Several institutional investors and hedge funds have recently made changes to their positions in DLB. Fifth Third Bancorp boosted its position in shares of Dolby Laboratories by 34.7% in the 4th quarter. Fifth Third Bancorp now owns 746 shares of the electronics maker’s stock worth $48,000 after purchasing an additional 192 shares during the last quarter. Aquatic Capital Management LLC acquired a new stake in shares of Dolby Laboratories during the third quarter worth $56,000. iSAM Funds UK Ltd bought a new stake in Dolby Laboratories in the third quarter valued at about $68,000. Allworth Financial LP increased its holdings in Dolby Laboratories by 99.6% in the third quarter. Allworth Financial LP now owns 1,006 shares of the electronics maker’s stock valued at $73,000 after purchasing an additional 502 shares during the last quarter. Finally, Quarry LP lifted its stake in Dolby Laboratories by 1,486.7% in the fourth quarter. Quarry LP now owns 1,190 shares of the electronics maker’s stock valued at $76,000 after buying an additional 1,115 shares during the period. Institutional investors own 58.56% of the company’s stock.

Dolby Laboratories Price Performance

DLB stock opened at $51.69 on Tuesday. The company has a 50 day moving average price of $52.21 and a 200 day moving average price of $58.58. Dolby Laboratories has a fifty-two week low of $48.26 and a fifty-two week high of $75.80. The stock has a market capitalization of $4.89 billion, a PE ratio of 20.43 and a beta of 0.81.

Dolby Laboratories (NYSE:DLB) last announced its quarterly earnings data on Thursday, July 30th. The electronics maker reported $0.69 EPS for the quarter, beating analysts’ consensus estimates of $0.67 by $0.02. The firm had revenue of $305.00 million for the quarter, compared to analyst estimates of $311.96 million. Dolby Laboratories had a return on equity of 11.47% and a net margin of 17.85%.The business’s quarterly revenue was down 3.3% compared to the same quarter last year. During the same period last year, the company earned $0.78 EPS. Dolby Laboratories has set its FY 2026 guidance at 4.250-4.400 EPS and its Q4 2026 guidance at 1.130-1.280 EPS. As a group, equities analysts expect that Dolby Laboratories will post 3.21 earnings per share for the current fiscal year.

Dolby Laboratories announced that its Board of Directors has approved a stock repurchase program on Thursday, July 30th that allows the company to buyback $350.00 million in shares. This buyback authorization allows the electronics maker to buy up to 7% of its stock through open market purchases. Stock buyback programs are generally an indication that the company’s board of directors believes its shares are undervalued.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.